Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Omni-Biotic Power is a probiotic dietary supplement developed by Institut AllergoSan to support gut health, immune function, and manage oxidative stress, particularly in athletes and physically active individuals. It contains a combination of six scientifically tested bacterial strains—*Enterococcus faecium* W54, *Lactobacillus acidophilus* W22, *Lactobacillus brevis* W63, *Lactococcus lactis* W58, *Bifidobacterium bifidum* W23, and *Bifidobacterium lactis* W51—along with magnesium citrate to support muscle function. The supplement works by strengthening the intestinal barrier and modulating the gut microbiome, which helps reduce markers of gut inflammation (such as zonulin) and oxidative stress (carbonyl proteins) induced by intense physical activity. It is formulated as a powder for oral administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Omni-Biotic Power.